A Federated Learning Protocol for Spiking Neural Membrane Systems.

Although deep learning models have shown promising results in solving problems related to image recognition or natural language processing, they do not match how the biological brain works. Some of the differences include the amount of energy consumed, the way neurons communicate, or the way they learn. To close the gap between artificial neural networks and biological ones, researchers proposed the spiking neural network.

On the Development of a New Flexible Pressure Sensor.

The rapid advancement of the Internet of Things (IoT) serves as a significant driving force behind the development of innovative sensors and actuators. This technological progression has created a substantial demand for new flexible pressure sensors, essential for a variety of applications ranging from wearable devices to smart home systems. In response to this growing need, our laboratory has developed a novel flexible pressure sensor, designed to offer an improved performance and adaptability.

The Clinical Efficacy, and Long-Term Outcomes Between Pneumatic Dilation and Laparoscopic Heller Myotomy in Achalasia.

Achalasia is the most well-known motility disorder, characterized by the lack of optimal relaxation of the lower esophageal sphincter during swallowing and the absence of peristalsis of the esophageal body. Laparoscopic Heller esocardiomyotomy (LHM) and pneumatic dilation (PD) were the main treatment options for achalasia. Currently, the therapeutic methods are complemented by per-oral endoscopic myotomy (POEM).

Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study.

Background: Antimicrobial resistance is a growing public health concern. There is a global need to estimate the population-level value of developing new antimicrobials and to ensure the effective use of existing antimicrobials as strategies to counteract antimicrobial resistance. To this aim, population-level value criteria need to be considered alongside conventional value measures.

Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom.

Introduction: Antimicrobial resistance remains a serious and growing threat to public health, both globally and in the UK, leading to diminishing effectiveness of antimicrobials. Despite a clear need for new antimicrobials, the clinical pipeline is insufficient, driven by high research and development costs and limited expected returns on investment. To counteract this, National Institute for Health and Care Excellence (NICE) and National Health Service (NHS) England have launched a reimbursement mechanism, de-linked from volume of sales, that aims to reduce economic risk by recognising the broader population-level value of antimicrobials.